Drug profile · INN
ibandronic acid
IBANDRONIC ACID SANDOZ
ibandronic acid (IBANDRONIC ACID SANDOZ) is a farnesyl diphosphate synthase inhibitor. Associated with Teva Pharma GmbH.
EMA: approved Musculo-skeletal system (M05) M05BA06
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — ibandronic acid
- Class
- Musculo-skeletal system (M05)
- Route
- —
- Patents
- 0
- Programs
- 2
- Data quality
- 0.89
Quick answer
ibandronic acid (IBANDRONIC ACID SANDOZ) is a farnesyl diphosphate synthase inhibitor. Associated with Teva Pharma GmbH.
Key facts
INN ibandronic acid
Brand IBANDRONIC ACID SANDOZ
Mechanism Farnesyl diphosphate synthase inhibitor
Therapeutic class Musculo-skeletal system (M05)
ATC code M05BA06
Originator Teva Pharma GmbH
Mechanism of action
Farnesyl diphosphate synthase inhibitor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is ibandronic acid?
ibandronic acid (IBANDRONIC ACID SANDOZ) is a farnesyl diphosphate synthase inhibitor. Associated with Teva Pharma GmbH.
What is the brand name for ibandronic acid?
IBANDRONIC ACID SANDOZ is a marketed brand name for ibandronic acid. Check FDA Drugs@FDA for the current US label holder and prescribing information.